These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention. Halken S. Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698 [Abstract] [Full Text] [Related]
9. Role of IgA1 protease-producing bacteria in SARS-CoV-2 infection and transmission: a hypothesis. Russell MW, Kilian M, Mestecky J. mBio; 2024 Oct 16; 15(10):e0083324. PubMed ID: 39207101 [Abstract] [Full Text] [Related]
14. Establishment of streptococci in the upper respiratory tract: longitudinal changes in the mouth and nasopharynx up to 2 years of age. Könönen E, Jousimies-Somer H, Bryk A, Kilpi T, Kilian M. J Med Microbiol; 2002 Sep 16; 51(9):723-730. PubMed ID: 12358062 [Abstract] [Full Text] [Related]
15. Maternal smoking and environmental tobacco smoke exposure and the risk of allergic diseases in Japanese infants: the Osaka Maternal and Child Health Study. Tanaka K, Miyake Y, Sasaki S, Ohya Y, Hirota Y, Osaka Maternal and Child Health Study Group. J Asthma; 2008 Nov 16; 45(9):833-8. PubMed ID: 18972305 [Abstract] [Full Text] [Related]
17. Comparison of throat swabs and nasopharyngeal suction specimens in non-sputum-producing patients with cystic fibrosis. Taylor L, Corey M, Matlow A, Sweezey NB, Ratjen F. Pediatr Pulmonol; 2006 Sep 16; 41(9):839-43. PubMed ID: 16850448 [Abstract] [Full Text] [Related]
18. Risk factors for acute wheezing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens. Duff AL, Pomeranz ES, Gelber LE, Price GW, Farris H, Hayden FG, Platts-Mills TA, Heymann PW. Pediatrics; 1993 Oct 16; 92(4):535-40. PubMed ID: 8414823 [Abstract] [Full Text] [Related]